EMEA (Europe, Middle East and Africa) Biosimilar Insulin Market Report 2017

October 2017 | 111 pages | ID: EF958E51A3DEN
QYResearch

Abstracts

In this report, the EMEA Biosimilar Insulin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Biosimilar Insulin for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biosimilar Insulin market competition by top manufacturers/players, with Biosimilar Insulin sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Biogenomics
• Eli Lilly
• Gan&Lee Pharmaceuticals
• Geropharm
• Julphar Gulf Pharmaceutical Industries
• Paras Biopharmaceuticals
• Samsung Bioepis
• Sedico
• Wockhardt
• Teva Pharmaceuticals

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• Rapid Acting Insulins
• Short Acting Insulins
• Intermediate Insulins
• Long Lasting Insulins

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Biosimilar Insulin for each application, including

• Hospital
• Clinic
• Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Biosimilar Insulin Market Report 2017

1 BIOSIMILAR INSULIN OVERVIEW

1.1 Product Overview and Scope of Biosimilar Insulin
1.2 Classification of Biosimilar Insulin
  1.2.1 EMEA Biosimilar Insulin Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Biosimilar Insulin Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Rapid Acting Insulins
  1.2.4 Short Acting Insulins
  1.2.5 Intermediate Insulins
  1.2.6 Long Lasting Insulins
1.3 EMEA Biosimilar Insulin Market by Application/End Users
  1.3.1 EMEA Biosimilar Insulin Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Medical Center
1.4 EMEA Biosimilar Insulin Market by Region
  1.4.1 EMEA Biosimilar Insulin Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biosimilar Insulin (2012-2022)
  1.5.1 EMEA Biosimilar Insulin Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Biosimilar Insulin Revenue and Growth Rate (2012-2022)

2 EMEA BIOSIMILAR INSULIN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Biosimilar Insulin Market Competition by Players/Manufacturers
  2.1.1 EMEA Biosimilar Insulin Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Biosimilar Insulin Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Biosimilar Insulin Sale Price by Players (2012-2017)
2.2 EMEA Biosimilar Insulin (Volume and Value) by Type/Product Category
  2.2.1 EMEA Biosimilar Insulin Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Biosimilar Insulin Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Biosimilar Insulin Sale Price by Type (2012-2017)
2.3 EMEA Biosimilar Insulin (Volume) by Application
2.4 EMEA Biosimilar Insulin (Volume and Value) by Region
  2.4.1 EMEA Biosimilar Insulin Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Biosimilar Insulin Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Biosimilar Insulin Sales Price by Region (2012-2017)

3 EUROPE BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Biosimilar Insulin Sales and Value (2012-2017)
  3.1.1 Europe Biosimilar Insulin Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Biosimilar Insulin Revenue and Growth Rate (2012-2017)
3.2 Europe Biosimilar Insulin Sales and Market Share by Type
3.3 Europe Biosimilar Insulin Sales and Market Share by Application
3.4 Europe Biosimilar Insulin Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Biosimilar Insulin Sales Volume by Countries (2012-2017)
  3.4.2 Europe Biosimilar Insulin Revenue by Countries (2012-2017)
  3.4.3 Germany Biosimilar Insulin Sales and Growth Rate (2012-2017)
  3.4.4 France Biosimilar Insulin Sales and Growth Rate (2012-2017)
  3.4.5 UK Biosimilar Insulin Sales and Growth Rate (2012-2017)
  3.4.6 Russia Biosimilar Insulin Sales and Growth Rate (2012-2017)
  3.4.7 Italy Biosimilar Insulin Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Biosimilar Insulin Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Biosimilar Insulin Sales and Value (2012-2017)
  4.1.1 Middle East Biosimilar Insulin Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Biosimilar Insulin Revenue and Growth Rate (2012-2017)
4.2 Middle East Biosimilar Insulin Sales and Market Share by Type
4.3 Middle East Biosimilar Insulin Sales and Market Share by Application
4.4 Middle East Biosimilar Insulin Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Biosimilar Insulin Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Biosimilar Insulin Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Biosimilar Insulin Sales and Growth Rate (2012-2017)
  4.4.4 Israel Biosimilar Insulin Sales and Growth Rate (2012-2017)
  4.4.5 UAE Biosimilar Insulin Sales and Growth Rate (2012-2017)
  4.4.6 Iran Biosimilar Insulin Sales and Growth Rate (2012-2017)

5 AFRICA BIOSIMILAR INSULIN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Biosimilar Insulin Sales and Value (2012-2017)
  5.1.1 Africa Biosimilar Insulin Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Biosimilar Insulin Revenue and Growth Rate (2012-2017)
5.2 Africa Biosimilar Insulin Sales and Market Share by Type
5.3 Africa Biosimilar Insulin Sales and Market Share by Application
5.4 Africa Biosimilar Insulin Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Biosimilar Insulin Sales Volume by Countries (2012-2017)
  5.4.2 Africa Biosimilar Insulin Revenue by Countries (2012-2017)
  5.4.3 South Africa Biosimilar Insulin Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Biosimilar Insulin Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Biosimilar Insulin Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Biosimilar Insulin Sales and Growth Rate (2012-2017)

6 EMEA BIOSIMILAR INSULIN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimilar Insulin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biogenomics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biosimilar Insulin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biogenomics Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biosimilar Insulin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gan&Lee Pharmaceuticals
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biosimilar Insulin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Geropharm
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Biosimilar Insulin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Geropharm Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Julphar Gulf Pharmaceutical Industries
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Biosimilar Insulin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Paras Biopharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Biosimilar Insulin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Paras Biopharmaceuticals Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Samsung Bioepis
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Biosimilar Insulin Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Samsung Bioepis Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sedico
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Biosimilar Insulin Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sedico Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Wockhardt
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Biosimilar Insulin Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Wockhardt Biosimilar Insulin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Teva Pharmaceuticals

7 BIOSIMILAR INSULIN MANUFACTURING COST ANALYSIS

7.1 Biosimilar Insulin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Insulin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilar Insulin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BIOSIMILAR INSULIN MARKET FORECAST (2017-2022)

11.1 EMEA Biosimilar Insulin Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Biosimilar Insulin Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Biosimilar Insulin Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Biosimilar Insulin Price and Trend Forecast (2017-2022)
11.2 EMEA Biosimilar Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biosimilar Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biosimilar Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biosimilar Insulin Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biosimilar Insulin Sales Forecast by Type (2017-2022)
11.7 EMEA Biosimilar Insulin Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biosimilar Insulin
Figure EMEA Biosimilar Insulin Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Biosimilar Insulin Sales Volume Market Share by Type (Product Category) in 2016
Figure Rapid Acting Insulins Product Picture
Figure Short Acting Insulins Product Picture
Figure Intermediate Insulins Product Picture
Figure Long Lasting Insulins Product Picture
Figure EMEA Biosimilar Insulin Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Biosimilar Insulin by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure EMEA Biosimilar Insulin Market Size (Million USD) by Region (2012-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biosimilar Insulin Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biosimilar Insulin Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biosimilar Insulin Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biosimilar Insulin Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biosimilar Insulin Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Biosimilar Insulin Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Biosimilar Insulin Sales Share by Players (2012-2017)
Figure 2016 Biosimilar Insulin Sales Share by Players
Figure 2017 Biosimilar Insulin Sales Share by Players
Figure EMEA Biosimilar Insulin Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biosimilar Insulin Revenue (Million USD) by Players (2012-2017)
Table EMEA Biosimilar Insulin Revenue Share by Players (2012-2017)
Table 2016 EMEA Biosimilar Insulin Revenue Share by Players
Table 2017 EMEA Biosimilar Insulin Revenue Share by Players
Table EMEA Biosimilar Insulin Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Biosimilar Insulin Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Biosimilar Insulin Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar Insulin by Type (2012-2017)
Figure EMEA Biosimilar Insulin Sales Market Share by Type (2012-2017)
Table EMEA Biosimilar Insulin Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biosimilar Insulin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Insulin by Type in 2016
Table EMEA Biosimilar Insulin Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Biosimilar Insulin Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Biosimilar Insulin Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar Insulin by Application (2012-2017)
Figure EMEA Biosimilar Insulin Sales Market Share by Application in 2016
Table EMEA Biosimilar Insulin Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Biosimilar Insulin Sales Share by Region (2012-2017)
Figure Sales Market Share of Biosimilar Insulin by Region (2012-2017)
Figure EMEA Biosimilar Insulin Sales Market Share in 2016
Table EMEA Biosimilar Insulin Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biosimilar Insulin Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biosimilar Insulin by Region (2012-2017)
Figure EMEA Biosimilar Insulin Revenue Market Share Regions in 2016
Table EMEA Biosimilar Insulin Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Biosimilar Insulin Revenue and Growth Rate (2012-2017)
Table Europe Biosimilar Insulin Sales (K Pcs) by Type (2012-2017)
Table Europe Biosimilar Insulin Market Share by Type (2012-2017)
Figure Europe Biosimilar Insulin Market Share by Type in 2016
Table Europe Biosimilar Insulin Sales (K Pcs) by Application (2012-2017)
Table Europe Biosimilar Insulin Market Share by Application (2012-2017)
Figure Europe Biosimilar Insulin Market Share by Application in 2016
Table Europe Biosimilar Insulin Sales (K Pcs) by Countries (2012-2017)
Table Europe Biosimilar Insulin Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilar Insulin Sales Market Share by Countries (2012-2017)
Figure Europe Biosimilar Insulin Sales Market Share by Countries in 2016
Table Europe Biosimilar Insulin Revenue (Million USD) by Countries (2012-2017)
Table Europe Biosimilar Insulin Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilar Insulin Revenue Market Share by Countries (2012-2017)
Figure Europe Biosimilar Insulin Revenue Market Share by Countries in 2016
Figure Germany Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biosimilar Insulin Sales (K Pcs) by Type (2012-2017)
Table Middle East Biosimilar Insulin Market Share by Type (2012-2017)
Figure Middle East Biosimilar Insulin Market Share by Type (2012-2017)
Table Middle East Biosimilar Insulin Sales (K Pcs) by Applications (2012-2017)
Table Middle East Biosimilar Insulin Market Share by Applications (2012-2017)
Figure Middle East Biosimilar Insulin Sales Market Share by Application in 2016
Table Middle East Biosimilar Insulin Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Biosimilar Insulin Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Insulin Sales Volume Market Share by Countries in 2016
Table Middle East Biosimilar Insulin Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biosimilar Insulin Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Insulin Revenue Market Share by Countries (2012-2017)
Figure Middle East Biosimilar Insulin Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Biosimilar Insulin Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biosimilar Insulin Sales (K Pcs) by Type (2012-2017)
Table Africa Biosimilar Insulin Sales Market Share by Type (2012-2017)
Figure Africa Biosimilar Insulin Sales Market Share by Type (2012-2017)
Figure Africa Biosimilar Insulin Sales Market Share by Type in 2016
Table Africa Biosimilar Insulin Sales (K Pcs) by Application (2012-2017)
Table Africa Biosimilar Insulin Sales Market Share by Application (2012-2017)
Figure Africa Biosimilar Insulin Sales Market Share by Application (2012-2017)
Table Africa Biosimilar Insulin Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Biosimilar Insulin Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilar Insulin Sales Market Share by Countries (2012-2017)
Figure Africa Biosimilar Insulin Sales Market Share by Countries in 2016
Table Africa Biosimilar Insulin Revenue (Million USD) by Countries (2012-2017)
Table Africa Biosimilar Insulin Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilar Insulin Revenue Market Share by Countries (2012-2017)
Figure Africa Biosimilar Insulin Revenue Market Share by Countries in 2016
Figure South Africa Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Table Pfizer Biosimilar Insulin Basic Information List
Table Pfizer Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Biogenomics Biosimilar Insulin Basic Information List
Table Biogenomics Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogenomics Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biogenomics Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Biogenomics Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biosimilar Insulin Basic Information List
Table Eli Lilly Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Gan&Lee Pharmaceuticals Biosimilar Insulin Basic Information List
Table Gan&Lee Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Gan&Lee Pharmaceuticals Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Geropharm Biosimilar Insulin Basic Information List
Table Geropharm Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Geropharm Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Geropharm Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Geropharm Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Basic Information List
Table Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Paras Biopharmaceuticals Biosimilar Insulin Basic Information List
Table Paras Biopharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Paras Biopharmaceuticals Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Samsung Bioepis Biosimilar Insulin Basic Information List
Table Samsung Bioepis Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Samsung Bioepis Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Sedico Biosimilar Insulin Basic Information List
Table Sedico Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sedico Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sedico Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Sedico Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Wockhardt Biosimilar Insulin Basic Information List
Table Wockhardt Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wockhardt Biosimilar Insulin Sales (K Pcs) and Growth Rate (2012-2017)
Figure Wockhardt Biosimilar Insulin Sales Market Share in EMEA (2012-2017)
Figure Wockhardt Biosimilar Insulin Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceuticals Biosimilar Insulin Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Insulin
Figure Manufacturing Process Analysis of Biosimilar Insulin
Figure Biosimilar Insulin Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Insulin Major Manufacturers in 2016
Table Major Buyers of Biosimilar Insulin
Table Distributors/Traders List
Figure EMEA Biosimilar Insulin Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilar Insulin Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biosimilar Insulin Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Biosimilar Insulin Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Biosimilar Insulin Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biosimilar Insulin Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biosimilar Insulin Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biosimilar Insulin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Biosimilar Insulin Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biosimilar Insulin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biosimilar Insulin Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilar Insulin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Biosimilar Insulin Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biosimilar Insulin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biosimilar Insulin Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilar Insulin Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Biosimilar Insulin Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biosimilar Insulin Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biosimilar Insulin Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biosimilar Insulin Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Biosimilar Insulin Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biosimilar Insulin Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Biosimilar Insulin Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources